Zobrazeno 1 - 10
of 63
pro vyhledávání: '"F. Figorilli"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
S Scrinzi, F Figorilli, S Sperandio, P Proto, C Costa, P Pallottino, C Colle, M Menesatti, M Macrì, A Antonucci
Publikováno v:
Forest@, Vol 14, Iss 1, Pp 124-134 (2017)
The aim of this work was to assess the economic sustainability of the implementation of a wood traceability system in Calabria based on RFID and open source technologies. We identified a break-even point in its implementation under different scenario
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fbb019288260d73c2f62ae69ebd655b
http://foresta.sisef.org/contents/?id=efor2267-014&lang=en
http://foresta.sisef.org/contents/?id=efor2267-014&lang=en
Autor:
Giacomo Flore, Elena Dore, Caterina Satta, Giancarlo Serra, Luchino Chessa, Francesco Arcadu, Enrico Urru, M. Conti, Davide Porcu, Simona Onali, F. Figorilli, Loredana Serusi, Ivana Maida, Maria Cristina Pasetto, Sergio Babudieri, C. Balestrieri, Maria Grazia Sanna, Martina Loi, M. Casale, Pier Paolo Bitti
Publikováno v:
Hepatitis Monthly. 18
Background: Hepatitis C virus (HCV) infection is a major cause of liver-related morbidity and mortality among thalassemic patients. New treatments based on direct-acting antivirals (DAAs) are highly effective and well-tolerated by patients; nonethele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53f7eb3d0b7f34a979d9e1e7fdfbaa23
https://doi.org/10.5812/hepatmon.61453
https://doi.org/10.5812/hepatmon.61453
Autor:
Cantone Stefania, Quaranta Maria Giovanna, Luchino Chessa, Conti Maria, Lucia Barca, S. Casu, F. Figorilli, Genovese Domenico, Laura Matta, Argentini Claudio, Balestrieri Cinzia, Pasetto Maria Cristina, M. Casale, Simona Onali, Vella Stefano, Rosetta Scioscia, I Canini, Serra Giancarlo
Publikováno v:
Hepatology. 62:714A-807A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff38c98a2f133205cf5e22e7e0fa825f
https://doi.org/10.1002/hep.28228
https://doi.org/10.1002/hep.28228
Autor:
Giancarlo Serra, S. Cappellini, C. Balestrieri, Carlo Carcassi, S. Casu, R. Porcella, F. Figorilli, Simona Onali, Laura Matta, L. Secci, Maria Cristina Pasetto, T. Zolfino, C. Salustro, Luchino Chessa, Lucia Barca, M. Casale, M. Conti, Roberto Littera, Sara Lai, Rosetta Scioscia
Publikováno v:
Hepatology. 62:363A-370A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11304a0b9698fbb65b251d8874140709
https://doi.org/10.1002/hep.28210
https://doi.org/10.1002/hep.28210
Publikováno v:
Liver.
Introduction The Albumin-Bilirubin (ALBI) grade, has been recently proposed for assessing liver function in patients with hepatocellular carcinoma (HCC) showing good performance in predicting survival after liver resection (LR) and loco-regional ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97d0aa3b6d0244f2a8007a106dee861e
https://doi.org/10.1136/gutjnl-2017-314472.313
https://doi.org/10.1136/gutjnl-2017-314472.313
Autor:
Giancarlo Senes, Gavino Faa, Luchino Chessa, Carlo Carcassi, E. Sanna, Daniela Fanni, C. Balestrieri, Marcello Trucas, F. Figorilli, Giancarlo Serra, Roberto Littera, A. Mereu, Simona Onali, F Alba, M. Conti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f0e044d9297d16d20269f10bbb05e98
http://hdl.handle.net/11573/1226582
http://hdl.handle.net/11573/1226582
Autor:
Valentina Loi, Roberto Littera, E Congeddu, R Maddi, Marcello Trucas, Giancarlo Serra, Paola Ragatzu, M. Casale, Carlo Carcassi, C. Balestrieri, Maria Pina Serra, Luchino Chessa, Simona Onali, F. Figorilli, F. Capraro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e63e96fc6de8f667033a66974f27a370
http://hdl.handle.net/11573/1226583
http://hdl.handle.net/11573/1226583
Autor:
Maria E Lai, Simona Onali, Giancarlo Serra, M. Conti, F. Figorilli, Rosetta Scioscia, Luchino Chessa, Lucia Barca, C. Balestrieri
Publikováno v:
Antiviral Therapy. 20:671-679
Background Infection with hepatitis delta virus (HDV) affects approximately 6–14.5% of patients coinfected with HIV-1 and HBV, showing a more aggressive clinical course compared with an HIV-negative population. There is no universally approved trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aeaf5b29dbdae4d0ce00229ebba4029e
https://doi.org/10.3851/imp2911
https://doi.org/10.3851/imp2911